LBT-3627
LBT-3627 is an experimental peptide drug derived from vasoactive intestinal peptide (VIP) that can change the behavior of immune cells so they protect dopamine-producing cells rather than attacking them.[1] The drug is being studied for its potential use for Parkinson's disease.[2]